Investor Slashes Million From Zymeworks as Stock Jumps 60%
A large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
Which Investors Should Avoid Robo Advisors outlines situations where automated options may underperform. This intro highlights alternatives to consider.
28,175 articlesA large holder trimmed a substantial stake in a biotech name while the stock advanced. This piece explains what inves...
SpaceX is rumored to pursue a summer IPO valued at about $1.5 trillion, a move that would reshape public market norms...
As Zillow prepares for 2026 earnings season, investors crave clarity on growth, margins, and how the housing cycle co...
Hedge-fund CIOs say the refining space offers persistent profit potential due to structural capacity limits, even as ...
Investing in rare earths sits at the intersection of policy, manufacturing demand, and new mining projects. This guid...
Newmont Mining stock rebounded on Friday as gold prices rallied and investors rotated into safe-haven assets. This gu...
An in-depth, grounded analysis of MDU Resources' Q1 2026 earnings call. Learn what to watch, how to model the numbers...
Nvidia is poised to deliver another strong earnings quarter, but history shows a big print doesn’t always move the st...
Rumble faces a pivotal quarter as it navigates growth, monetization, and cost control. This article breaks down what ...
Investors are zooming in on InspireMD after its Q1 2026 earnings. This detailed look breaks down the numbers, the pro...
As biotech manufacturing accelerates, repligen (rgen) 2025 earnings will shape how investors price the stock. This gu...
Berkshire Hathaway’s massive cash pile has long frustrated investors. Now the company is finally putting some of that...